Back to Journals » OncoTargets and Therapy » Volume 11

CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis

Total article views   Abstract views HTML views PDF downloads Totals
3,257 Dovepress* 2,387 567+ 790 2,954
PubMed Central* 0 303 88 303
Totals 2,387 870 878 3,257
*Since 27 February 2018
+Since July 2016

View citations on PubMed Central and Google Scholar